Araştırma Makalesi
BibTex RIS Kaynak Göster

Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution

Yıl 2021, Cilt: 48 Sayı: 4, 662 - 668, 01.12.2021
https://doi.org/10.5798/dicletip.1001875

Öz

Objective: Supraventricular tachycardia, one of the most common conditions requiring emergency cardiac intervention in newborns, is also the most common symptomatic tachyarrhythmia in newborns. Therefore, early diagnosis and treatment approach is important.
Method: Demographic findings, clinical findings, and treatment approaches of newborns hospitalized with the diagnosis of supraventricular tachycardia between January 2011 and November 2020 in the Neonatal Intensive Care Unit of our hospital were evaluated retrospectively.
Results: Thirty-eight patients without congenital heart disease (except secundum-type atrial septal defect) and diagnosed with supraventricular tachycardia were evaluated retrospectively. The mean week of gestation was 38.2 ± 1.8, the mean age at diagnosis was 10.7 ± 10.1 days, the number of patients with heart failure was 8 (21%), the number of patients with Wolff-Parkinson White syndrome was 8 (21%), the number of patients with fetal arrhythmia was 6 (15.7%) and the mean number of hospitalization days was 15.7±13.5. The patients were given adenosine in the first stage and propranolol, amiodarone, propafenone and flecainide in the second stage as medical treatment. Cardioversion was performed in 5 (13%) patients due to resistant supraventricular tachycardia.
Conclusion: Early diagnosis and treatment of supraventricular tachycardia are very important in terms of reducing morbidity and mortality. Therefore, we think that increasing awareness of supraventricular tachycardia among clinicians following newborn babies will enable newborns with supraventricular tachycardia to receive early diagnosis and treatment.

Kaynakça

  • 1. Spearman AD, Williams P. Supraventricular tachycardia in infancy and childhood. Pediatric annals. 2014; 43: 456-60.
  • 2. O'Connor BK, Dick M, 2nd. What every pediatrician should know about supraventricular tachycardia. Pediatric annals. 1991; 20: 368,71-6.
  • 3. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta paediatrica. 2008; 97: 1035-39.
  • 4. Srinivasan C, Balaji S. Neonatal supraventricular tachycardia. Indian Pacing Electrophysiol J. 2019; 19: 222-31.
  • 5. Bilici M, Demir F. Pediatrik disritmiler. Dicle Tıp Dergisi. 2015; 42: 128-35.

Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution

Yıl 2021, Cilt: 48 Sayı: 4, 662 - 668, 01.12.2021
https://doi.org/10.5798/dicletip.1001875

Öz

Objective: Supraventricular tachycardia, one of the most common conditions requiring emergency cardiac intervention in newborns, is also the most common symptomatic tachyarrhythmia in newborns. Therefore, early diagnosis and treatment approach is important.
Method: Demographic findings, clinical findings, and treatment approaches of newborns hospitalized with the diagnosis of supraventricular tachycardia between January 2011 and November 2020 in the Neonatal Intensive Care Unit of our hospital were evaluated retrospectively.
Results: Thirty-eight patients without congenital heart disease (except secundum-type atrial septal defect) and diagnosed with supraventricular tachycardia were evaluated retrospectively. The mean week of gestation was 38.2 ± 1.8, the mean age at diagnosis was 10.7 ± 10.1 days, the number of patients with heart failure was 8 (21%), the number of patients with Wolff-Parkinson White syndrome was 8 (21%), the number of patients with fetal arrhythmia was 6 (15.7%) and the mean number of hospitalization days was 15.7±13.5. The patients were given adenosine in the first stage and propranolol, amiodarone, propafenone and flecainide in the second stage as medical treatment. Cardioversion was performed in 5 (13%) patients due to resistant supraventricular tachycardia.
Conclusion: Early diagnosis and treatment of supraventricular tachycardia are very important in terms of reducing morbidity and mortality. Therefore, we think that increasing awareness of supraventricular tachycardia among clinicians following newborn babies will enable newborns with supraventricular tachycardia to receive early diagnosis and treatment.

Kaynakça

  • 1. Spearman AD, Williams P. Supraventricular tachycardia in infancy and childhood. Pediatric annals. 2014; 43: 456-60.
  • 2. O'Connor BK, Dick M, 2nd. What every pediatrician should know about supraventricular tachycardia. Pediatric annals. 1991; 20: 368,71-6.
  • 3. Gilljam T, Jaeggi E, Gow RM. Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta paediatrica. 2008; 97: 1035-39.
  • 4. Srinivasan C, Balaji S. Neonatal supraventricular tachycardia. Indian Pacing Electrophysiol J. 2019; 19: 222-31.
  • 5. Bilici M, Demir F. Pediatrik disritmiler. Dicle Tıp Dergisi. 2015; 42: 128-35.
Toplam 5 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Original Articles
Yazarlar

Hasan Akduman Bu kişi benim

Dilek Dilli Bu kişi benim

Senem Özgür Bu kişi benim

Başak Kaya Gürsoy Bu kişi benim

Utku Arman Örün Bu kişi benim

Seda Aydoğan Bu kişi benim

Rumeysa Çitli Bu kişi benim

Nurdan Dinlen Fettah Bu kişi benim

Serpil Kaya Çelebi Bu kişi benim

Ayşegül Zenciroğlu Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2021
Gönderilme Tarihi 14 Temmuz 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 48 Sayı: 4

Kaynak Göster

APA Akduman, H., Dilli, D., Özgür, S., Kaya Gürsoy, B., vd. (2021). Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution. Dicle Medical Journal, 48(4), 662-668. https://doi.org/10.5798/dicletip.1001875
AMA Akduman H, Dilli D, Özgür S, Kaya Gürsoy B, Örün UA, Aydoğan S, Çitli R, Dinlen Fettah N, Kaya Çelebi S, Zenciroğlu A. Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution. diclemedj. Aralık 2021;48(4):662-668. doi:10.5798/dicletip.1001875
Chicago Akduman, Hasan, Dilek Dilli, Senem Özgür, Başak Kaya Gürsoy, Utku Arman Örün, Seda Aydoğan, Rumeysa Çitli, Nurdan Dinlen Fettah, Serpil Kaya Çelebi, ve Ayşegül Zenciroğlu. “Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution”. Dicle Medical Journal 48, sy. 4 (Aralık 2021): 662-68. https://doi.org/10.5798/dicletip.1001875.
EndNote Akduman H, Dilli D, Özgür S, Kaya Gürsoy B, Örün UA, Aydoğan S, Çitli R, Dinlen Fettah N, Kaya Çelebi S, Zenciroğlu A (01 Aralık 2021) Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution. Dicle Medical Journal 48 4 662–668.
IEEE H. Akduman, “Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution”, diclemedj, c. 48, sy. 4, ss. 662–668, 2021, doi: 10.5798/dicletip.1001875.
ISNAD Akduman, Hasan vd. “Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution”. Dicle Medical Journal 48/4 (Aralık 2021), 662-668. https://doi.org/10.5798/dicletip.1001875.
JAMA Akduman H, Dilli D, Özgür S, Kaya Gürsoy B, Örün UA, Aydoğan S, Çitli R, Dinlen Fettah N, Kaya Çelebi S, Zenciroğlu A. Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution. diclemedj. 2021;48:662–668.
MLA Akduman, Hasan vd. “Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution”. Dicle Medical Journal, c. 48, sy. 4, 2021, ss. 662-8, doi:10.5798/dicletip.1001875.
Vancouver Akduman H, Dilli D, Özgür S, Kaya Gürsoy B, Örün UA, Aydoğan S, Çitli R, Dinlen Fettah N, Kaya Çelebi S, Zenciroğlu A. Neonatal Supraventricular Tachycardia: Outcomes Over a 10-Year Period at a Single Institution. diclemedj. 2021;48(4):662-8.